An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action
Philippe Nuss,1,2 Florian Ferreri,1 Michel Bourin31Department of Adult Psychiatry and Medical Psychology, Sorbonne University, Saint-Antoine Hospital, Paris, France; 2Inserm UMR_S938, Saint-Antoine Research Centre, Sorbonne University, Paris, France; 3Department of Neurobiology of Anxiety a...
Main Authors: | Nuss P, Ferreri F, Bourin M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/an-update-on-the-anxiolytic-and-neuroprotective-properties-of-etifoxin-peer-reviewed-article-NDT |
Similar Items
-
NEUROTROPHIC EFFECTS OF ETIFOXINE
by: I. Yu. Torshin, et al.
Published: (2016-12-01) -
Translocator Protein Ligand Etifoxine Attenuates MPTP-Induced Neurotoxicity
by: Qi Tian, et al.
Published: (2022-05-01) -
Effects of etifoxine: Chemoreactome simulation
by: I. Yu. Torshin, et al.
Published: (2016-07-01) -
A translocator protein 18 kDa agonist protects against cerebral ischemia/reperfusion injury
by: Han-Dong Li, et al.
Published: (2017-07-01) -
Translocator protein in the rise and fall of central nervous system neurons
by: Garett Cheung, et al.
Published: (2023-06-01)